Evidence map›Paper›PMID 25212617›Full record

ArticleGenome announcements2014

De Novo Whole-Genome Sequence and Genome Annotation of Lichtheimia ramosa.

Jörg Linde, Volker Schwartze, Ulrike Binder, Cornelia Lass-Flörl, Kerstin Voigt, Fabian Horn

Open access · diamondAbstract read
In one paragraph

Article in Genome announcements, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Discovery of a NewJournal of fungi (Basel, Switzerland) · 2023
    Article
  5. Comparative Genomics ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Inhibition of growth and ochratoxin A production in Aspergillus species by fungi isolated from coffee beans.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2019
    Article
  10. Genome sequence ofBiotechnology reports (Amsterdam, Netherlands) · 2018
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jörg LindeSystems Biology/Bioinformatics, Hans-Knöll-Institut, Jena, Germany.
Volker SchwartzeJena Microbial Resource Collection, Hans-Knöll-Institut, Jena, Germany.
Ulrike BinderDivision of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria.
Cornelia Lass-FlörlDivision of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria.
Kerstin VoigtJena Microbial Resource Collection, Hans-Knöll-Institut, Jena, Germany kerstin.voigt@hki-jena.de fabian.horn@hki-jena.de.
Fabian HornSystems Biology/Bioinformatics, Hans-Knöll-Institut, Jena, Germany kerstin.voigt@hki-jena.de fabian.horn@hki-jena.de.
Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DEInnsbruck Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the annotated draft genome sequence of Lichtheimia ramosa (JMRC FSU:6197). It has been reported to be a causative organism of mucormycosis, a rare but rapidly progressive infection in immunocompromised humans. The functionally annotated genomic sequence consists of 74 scaffolds with a total number of 11,510 genes.

Identifiers

PMID25212617
PMCPMC4161746
OpenAlexW1990263257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.